Aussie Court Upholds Myriad's Breast Cancer Gene Patent
An Australian court on Friday found Myriad Genetics Inc.'s patent covering an isolated human gene associated with breast and ovarian cancer is valid, finding that the separation of the genetic material...To view the full article, register now.
Already a subscriber? Click here to view full article